theodi/ndl-core-corpus huggingface dataset:
NPDA 2023-24 unit, regional and national data
Source: data.gov.uk (2025-04-04)

National Paediatric Diabetes Audit 2023 - 2024. The excel file contains unit, regional and national level data obtained from the National Paediatric Diabetes Audit 2023-2024.

Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2023 and the 31 March 2024.

Data are included for the six key health checks: • Glycated Haemoglobin A1c (HbA1c) • Body Mass Index (BMI) • Thyroid • Blood pressure • Urinary albumin • Eye screening.

Data on other health checks include: • Psychological assessment • Offering of immunisation against influenza • Advice about managing diabetes (‘sick-day rules’) • Using (or trained to use) blood ketone testing strips and a meter • Cholesterol • Additional dietetic support

Data are included for health checks at diagnosis • Screening for autoimmune disease (coeliac and thyroid disease) • Provision of Level 3 carbohydrate-counting education

Data on outcomes of care include: • HbA1c target measurements • Small vessel (microvascular) disease • Large vessel (macrovascular) disease • Autoimmune disease (coeliac and thyroid disease)

The data were first published in 2025 alongside the National Paediatric Diabetes Audit Report 2023-2024 Data suppressed due to small numbers (<5).

For further information and details on the audit please refer to: 

• National Paediatric Diabetes Audit Annual Reports: https://www.rcpch.ac.uk/resources/npda-annual-reports
• NPDA Annual Dashboard:
https://www.rcpch.ac.uk/resources/NPDA-dashboard
• RCPCH Website:
https://www.rcpch.ac.uk/work-we-do/clinical-audits/npda
NPDA 2023-24 ICS data
Source: data.gov.uk (2025-04-04)

National Paediatric Diabetes Audit 2023 - 2024. The excel file contains unit, regional and national level data obtained from the National Paediatric Diabetes Audit 2023-2024.

Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2023 and the 31 March 2024.

Data are included for the six key health checks: • Glycated Haemoglobin A1c (HbA1c) • Body Mass Index (BMI) • Thyroid • Blood pressure • Urinary albumin • Eye screening.

Data on other health checks include: • Psychological assessment • Offering of immunisation against influenza • Advice about managing diabetes (‘sick-day rules’) • Using (or trained to use) blood ketone testing strips and a meter • Cholesterol • Additional dietetic support

Data are included for health checks at diagnosis • Screening for autoimmune disease (coeliac and thyroid disease) • Provision of Level 3 carbohydrate-counting education

Data on outcomes of care include: • HbA1c target measurements • Small vessel (microvascular) disease • Large vessel (macrovascular) disease • Autoimmune disease (coeliac and thyroid disease)

The data were first published in 2025 alongside the National Paediatric Diabetes Audit Report 2023-2024 Data suppressed due to small numbers (<5).

For further information and details on the audit please refer to: 

• National Paediatric Diabetes Audit Annual Reports: https://www.rcpch.ac.uk/resources/npda-annual-reports
• NPDA Annual Dashboard:
https://www.rcpch.ac.uk/resources/NPDA-dashboard
• RCPCH Website:
https://www.rcpch.ac.uk/work-we-do/clinical-audits/npda
2020 Annual Report Data Tables
Source: data.gov.uk (2021-02-08)

National Oesophago-Gastric Cancer Audit (NOGCA) 2020. The National Oesophago-Gastric Cancer Audit evaluates the quality of care given to patients with oesophago-gastric (OG) cancer and patients with oesophageal high grade dysplasia (HGD). The audit aims to support NHS services to improve the quality of care delivered to these patients.

The National Oesophago-Gastric Cancer Audit is a collaborative, national clinical audit run by the Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG), Royal College of Radiologists, NHS Digital, and the Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), that is managed by the Healthcare Quality Improvement Partnership.

The NOGCA data file contains the results published within the 2020 Annual Report for English NHS trusts and Welsh health boards. The organisational figures are based on data from patients diagnosed with OG cancer or HGD up to 31 March 2019.

The data file contains information on: 
• Audit participation by NHS organisation and data completeness for the key fields. 
• Measures about the process of care given to patients. 
• Information about care outcomes and treatment.

These data files do not contain individual patient information, nor do they contain any patient identifiable data.
2020 Annual Report Data Viewer
Source: data.gov.uk (2021-02-08)

National Oesophago-Gastric Cancer Audit (NOGCA) 2020. The National Oesophago-Gastric Cancer Audit evaluates the quality of care given to patients with oesophago-gastric (OG) cancer and patients with oesophageal high grade dysplasia (HGD). The audit aims to support NHS services to improve the quality of care delivered to these patients.

The National Oesophago-Gastric Cancer Audit is a collaborative, national clinical audit run by the Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG), Royal College of Radiologists, NHS Digital, and the Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), that is managed by the Healthcare Quality Improvement Partnership.

The NOGCA data file contains the results published within the 2020 Annual Report for English NHS trusts and Welsh health boards. The organisational figures are based on data from patients diagnosed with OG cancer or HGD up to 31 March 2019.

The data file contains information on: 
• Audit participation by NHS organisation and data completeness for the key fields. 
• Measures about the process of care given to patients. 
• Information about care outcomes and treatment.

These data files do not contain individual patient information, nor do they contain any patient identifiable data.
NAoPri State of the Nation Report 2025 Data Tables
Source: data.gov.uk (2025-09-15)

National Audit of Primary Breast Cancer (NAoPri) State of the Nation Report 2025. The aim of the National Audit of Primary Breast Cancer (NAoPri) is to evaluate the patterns of care and outcomes for people with primary breast cancer in England and Wales, and to support services to improve the quality of care for these patients.

This State of the Nation report (SotN) publishes information on the care received by people diagnosed with primary breast cancer during 2020-22 in England and Wales. It is the audit’s first annual assessment of NHS breast services and shares examples of good practice as well as highlighting where care needs to improve.

The SotN report includes performance indicators outlined in the Quality Improvement Plan (QIP). The QIP also sets out the audit scope, care pathway and five quality improvement (QI) goals.

Findings in the SotN report lead to five recommendations highlighting where improvements in care are needed. These recommendations are aligned to the QI goals of the NAoPri.

A Data Dashboard provides results for individual organisations enabling regional and national comparisons to support local QI, in addition to an Action Plan Template to support MDT discussions.

The audit uses information that is routinely collected by the NHS. For people treated within English NHS hospitals, the data are routinely collated, maintained and quality-assured by the National Disease Registration Service (NDRS), which is part of NHS England. For people treated in Wales, the data were provided by the Wales Cancer Network (WCN) in Public Health Wales, from the Cancer Network Information System Cymru (CaNISC) electronic patient record system. A Methodology Document provides information on the data and methods used in this report.

To further support QI activities, the NAoPri publishes quarterly reports of data quality metrics and patient characteristics (England only). From October 2024 these reports will include a subset of performance indicators. These quarterly reports are work in progress and will be further developed in the next 12 months.